Bluepoint Partners, a leading deeptech accelerator in Korea, has raised 10 billion won (approximately $6.8 million USD) to enhance its early-stage investment capabilities.

The funding round was jointly led by Z Venture Capital (ZVC) and global healthcare company InBody, each contributing 5 billion won ($3.4 million USD). ZVC is the corporate venture capital arm of LY Corporation, a joint venture between Naver and SoftBank under A Holdings.

The capital will be deployed to discover and invest in startups with global competitiveness while strengthening technology commercialization processes.

Beyond capital injection, this investment marks a strategic partnership aimed at maximizing synergies. Bluepoint will leverage its deep tech expertise and commercialization capabilities alongside ZVC and InBody’s global networks and resources.

Through ZVC, Bluepoint plans to tap into networks in Japan and the United States, creating global testbeds for its portfolio companies. ZVC will also actively discover and collaborate with world-class Korean deep tech startups through this partnership.

With InBody, Bluepoint aims to accelerate innovation across bio, healthcare, and various other industries using startup methodologies. The partnership will adopt an accelerating approach to leverage InBody’s technology, infrastructure, and human resources for rapid market exploration and growth.

Bluepoint has been consistently investing in technology-intensive sectors that domestic investors rarely touch, including nuclear fusion, quantum computing, and defense AI. Building on this expertise, the firm is currently collaborating with major corporations including LG Electronics, LG Uplus, HD Hyundai Electric, and POSCO Holdings.

Injoon Hwang, CEO of ZVC, stated, “Bluepoint Partners is the optimal partner with unparalleled positioning in the deep tech sector, where technical expertise and early-stage validation capabilities are essential. Through this investment, ZVC will make a full-scale entry into Korea’s deep tech ecosystem and actively support Korean tech companies’ global growth by combining both parties’ strengths.”

Yongkwan Lee, CEO of Bluepoint Partners, commented, “This investment validates once again the investment expertise we’ve accumulated in early-stage and deep tech sectors over the past decade. Together with global companies ZVC and InBody, we will lead Korean deep tech startups’ global advancement.”

Founded in 2014, Bluepoint Partners is a leading Korean accelerator that has invested in over 400 companies. Notable investment successes include KOSDAQ listings of Tomocube, Inventage Lab, S2W, and Nota. The firm was also selected as entrepreneurs’ most preferred accelerator by Startup Alliance for two consecutive years in 2023 and 2024.